DIFFERENTIAL PATHWAY DEPENDENCY DISCOVERY ASSOCIATED WITH DRUG RESPONSE ACROSS CANCER CELL LINES.
DIFFERENTIAL PATHWAY DEPENDENCY DISCOVERY ASSOCIATED WITH DRUG RESPONSE ACROSS CANCER CELL LINES.
复制标题
DOI：
10.1142/9789813207813_0046
复制
发表时间：
2017
影响因子：
--
通讯作者：
Kim S
中科院分区：
文献类型：
--
作者：
Speyer G;Mahendra D;Tran HJ;Kiefer J;Schreiber SL;Clemons PA;Dhruv H;Berens M;Kim S
The effort to personalize treatment plans for cancer patients involves the identification of drug treatments that can effectively target the disease while minimizing the likelihood of adverse reactions. In this study, the gene-expression profile of 810 cancer cell lines and their response data to 368 small molecules from the Cancer Therapeutics Research Portal (CTRP) are analyzed to identify pathways with significant rewiring between genes, or differential gene dependency, between sensitive and non-sensitive cell lines. Identified pathways and their corresponding differential dependency networks are further analyzed to discover essentiality and specificity mediators of cell line response to drugs/compounds. For analysis we use the previously published method EDDY (Evaluation of Differential DependencY). EDDY first constructs likelihood distributions of gene-dependency networks, aided by known gene-gene interaction, for two given conditions, for example, sensitive cell lines vs. non-sensitive cell lines. These sets of networks yield a divergence value between two distributions of network likelihoods that can be assessed for significance using permutation tests. Resulting differential dependency networks are then further analyzed to identify genes, termed mediators, which may play important roles in biological signaling in certain cell lines that are sensitive or non-sensitive to the drugs. Establishing statistical correspondence between compounds and mediators can improve understanding of known gene dependencies associated with drug response while also discovering new dependencies. Millions of compute hours resulted in thousands of these statistical discoveries. EDDY identified 8,811 statistically significant pathways leading to 26,822 compound-pathway-mediator triplets. By incorporating STITCH and STRING databases, we could construct evidence networks for 14,415 compound-pathway-mediator triplets for support. The results of this analysis are presented in a searchable website to aid researchers in studying potential molecular mechanisms underlying cells’ drug response as well as in designing experiments for the purpose of personalized treatment regimens.
登录
查看更多内容
影响因子：
5.9
作者：
Masson N;Ratcliffe PJ
通讯作者：
Ratcliffe PJ
影响因子：
6.7
作者：
通讯作者：
--
解剖小鼠乳腺肿瘤中细胞过程失调的动力学。
影响因子：
4.4
作者：
Mentzen WI;Floris M;de la Fuente A
通讯作者：
de la Fuente A
影响因子：
3
作者：
Hwang T;Park T
通讯作者：
Park T
DOI：
10.1287/mnsc.17.11.712
发表时间：
1971-01-01
期刊：
MANAGEMENT SCIENCE SERIES A-THEORY
影响因子：
--
作者：
YEN, JY
通讯作者：
YEN, JY